These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8463450)

  • 21. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD; Libb JW; Spitler D
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyl cysteine in the treatment of grooming disorders.
    Odlaug BL; Grant JE
    J Clin Psychopharmacol; 2007 Apr; 27(2):227-9. PubMed ID: 17414258
    [No Abstract]   [Full Text] [Related]  

  • 23. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J; Olivares J; Marcos T; Bulbena A; Menchón JM
    Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.
    Kasvikis Y; Marks IM
    Psychopharmacology (Berl); 1988; 95(1):113-8. PubMed ID: 3133689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clomipramine for obsessive-compulsive disorder: prescribing guidelines.
    James WA; Lippmann SB
    South Med J; 1991 Oct; 84(10):1243-5. PubMed ID: 1925726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attacks of jealousy that responded to clomipramine.
    Lawrie SM
    J Clin Psychiatry; 1998 Jun; 59(6):317-8. PubMed ID: 9671346
    [No Abstract]   [Full Text] [Related]  

  • 27. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.
    DeVeaugh-Geiss J; Moroz G; Biederman J; Cantwell D; Fontaine R; Greist JH; Reichler R; Katz R; Landau P
    J Am Acad Child Adolesc Psychiatry; 1992 Jan; 31(1):45-9. PubMed ID: 1537780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement with 17β-estradiol plus dihydrotestosterone restores male sexual behavior in rats treated neonatally with clomipramine.
    Limón-Morales O; Soria-Fregozo C; Arteaga-Silva M; González MH; Vázquez-Palacios G; Bonilla-Jaime H
    Horm Behav; 2014 Nov; 66(5):820-7. PubMed ID: 25449595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clomipramine in the elderly: tolerance and plasma levels.
    Kunik ME; Pollock BG; Perel JM; Altieri L
    J Geriatr Psychiatry Neurol; 1994; 7(3):139-43. PubMed ID: 7916936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clomipramine treatment of repetitive behavior.
    Pulman J; Yassa R; Ananth J
    Can J Psychiatry; 1984 Apr; 29(3):254-5. PubMed ID: 6529718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M; Jones B; Olson S; Perel JM
    Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
    Alarcon RD; Johnson BR; Lucas JP
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):999-1002. PubMed ID: 1757451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clomipramine on monoamine metabolites in the cerebrospinal fluid of behaviorally normal dogs.
    Hewson CJ; Luescher UA; Parent JM; Ball RO
    Can J Vet Res; 2000 Apr; 64(2):123-9. PubMed ID: 10805252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sexual dysfunction and clomipramine.
    Quirk KC; Einarson TR
    Can J Psychiatry; 1982 Apr; 27(3):228-31. PubMed ID: 7201341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A control study of clomipramine and amitriptyline for treating obsessive-compulsive disorder].
    Zhao JP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Apr; 24(2):68-70, 123. PubMed ID: 1860383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
    Mavissakalian MR; Jones B; Olson S; Perel JM
    J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compulsive buying and sexual attitudes, intentions, and activity among adolescents: an extension of Roberts and Tanner (2000).
    Roberts JA; Tanner JF
    Psychol Rep; 2002 Jun; 90(3 Pt 2):1259-60. PubMed ID: 12150415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.